Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Atossa Therapeutics, Inc.

NASDAQ: ATOS · Life Sciences · 5 alerts · CIK 1488039

Share price
$1.93Close, Nov 16
Market cap
$19.3M
Shares outstanding
9.98MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Atossa Therapeutics, Inc. filings on SEC EDGAR ↗

5:01 PM ET 8-K
Investor Presentation

Atossa Therapeutics Investor Presentation

Atossa Therapeutics made available an updated corporate and investor presentation on September 18, 2026, highlighting its clinical development strategy for (Z)-Endoxifen. The presentation covers the company's oncology core and rare disease expansion, including Phase 2 progress in breast cancer and regulatory designations for McCune-Albright Syndrome and Duchenne Muscular Dystrophy.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.